Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Seule, M; Muroi, C; Sikorski, C; Hugelshofer, M; Winkler, K; Keller, E (2014). Therapeutic hypothermia reduces middle cerebral artery flow velocity in patients with severe aneurysmal subarachnoid hemorrhage. Neurocritical Care, 20(2):255-262.

Muroi, C; Lemb, J B; Hugelshofer, M; Seule, M A; Bellut, D; Keller, E (2014). Early systemic procalcitonin levels in patients with aneurysmal subarachnoid hemorrhage. Neurocritical Care, 21(1):73-77.

Muroi, C; Hugelshofer, M; Seule, M A; Keller, E (2014). The impact of nonsteroidal anti-inflammatory drugs on inflammatory response after aneurysmal subarachnoid hemorrhage. Neurocritical Care, 20(2):240-246.

Muroi, C; Hugelshofer, M; Seule, M A; Tastan, I; Fujioka, M; Mishima, K; Keller, E (2013). Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery, 72(3):367-375.

Muroi, C; Burkhardt, J K; Hugelshofer, M; Seule, M; Mishima, K; Keller, E (2012). Magnesium and the inflammatory response: potential pathophysiological implications in the management of patients with aneurysmal subarachnoid hemorrhage? Magnesium Research, 25(2):64-71.

Hugelshofer, M; Achermann, Y; Kovari, H; Dent, W; Hombach, M; Bloemberg, G (2012). Meningoencephalitis with Subdural Empyema Caused by Toxigenic Clostridium perfringens Type A. Journal of Clinical Microbiology, 50(10):3409-3411.

Hugelshofer, M. Effective surgical treatment of cerebral cavernous malformations. 2011, University of Zurich, Faculty of Medicine.

This list was generated on Sun Apr 21 19:45:38 2019 CEST.